Huxley R, James WP, Barzi F, et al. Ethnic comparisons of the cross-sectional relationships between measures of body size with diabetes and hypertension. Obes Rev. 2008;9(Suppl 1):53–61.
Article
Google Scholar
Chan JC, Malik V, Jia W, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009;301:2129–40.
CAS
Article
Google Scholar
Ramachandran A, Snehalatha C, Shetty AS, Nanditha A. Trends in prevalence of diabetes in Asian countries. World J Diabetes. 2012;3:110–7.
Article
Google Scholar
Ma RC, Chan JC. Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States. Ann N Y Acad Sci. 2013;1281:64–91.
Article
Google Scholar
Kang X, Wang C, Lifang L, et al. Effects of different proportion of carbohydrate in breakfast on postprandial glucose excursion in normal glucose tolerance and impaired glucose regulation subjects. Diabetes Technol Ther. 2013;15:569–74.
CAS
Article
Google Scholar
Atkinson FS, Foster-Powell K, Brand-Miller JC. International tables of glycemic index and glycemic load values: 2008. Diabetes Care. 2008;31:2281–3.
Article
Google Scholar
Gagné L. The glycemic index and glycemic load in clinical practice. Explore (NY). 2008;4:66–9.
Article
Google Scholar
Livesey G, Taylor R, Livesey H, Liu S. Is there a dose-response relation of dietary glycemic load to risk of type 2 diabetes? Meta-analysis of prospective cohort studies. Am J Clin Nutr. 2013;97:584–96.
CAS
Article
Google Scholar
Dong JY, Zhang L, Zhang YH, Qin LQ. Dietary glycaemic index and glycaemic load in relation to the risk of type 2 diabetes: a meta-analysis of prospective cohort studies. Br J Nutr. 2011;106:1649–54.
CAS
Article
Google Scholar
Ludwig DS. The glycemic index: physiological mechanisms relating to obesity, diabetes, and cardiovascular disease. JAMA. 2002;287:2414–23.
CAS
Article
Google Scholar
The Diabetes Control and Complications Trial Research Group, Nathan DM, Genuth S, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–86.
Article
Google Scholar
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–53.
Article
Google Scholar
Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321:405–12.
CAS
Article
Google Scholar
Patel A, MacMahon S, Chalmers J, The ADVANCE Collaborative Group, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358:2560–72.
CAS
Article
Google Scholar
Gerstein HC, Miller ME, Byington RP, Action to Control Cardiovascular Risk in Diabetes Study Group, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545–59.
CAS
Article
Google Scholar
Duckworth W, Abraira C, Moritz T, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360:129–39.
CAS
Article
Google Scholar
Tay J, Thompson CH, Brinkworth GD. Glycemic variability: assessing glycemia differently and the implications for dietary management of diabetes. Annu Rev Nutr. 2015;35:389–424.
CAS
Article
Google Scholar
Satya Krishna SV, Kota SK, Modi KD. Glycemic variability: clinical implications. Indian J Endocrinol Metab. 2013;17:611–9.
Article
Google Scholar
US Food and Drug Administration. Guidance for industry diabetes mellitus: developing drugs and therapeutic biologics for treatment and prevention. 2008. http://www.fda.gov/downloads/Drugs/Guidancecomplianceregulatoryinformation/Guidances/ucm071624.pdf. Accessed 19 May 2017.
Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia. 2015;58:429–42.
Article
Google Scholar
Chinese Diabetes Society. Chinese guidelines for the management of type 2 diabetes mellitus (2013 edition). Chin J Diabetes Mellitus. 2013;6:447–98.
Woerle HJ, Neumann C, Zschau S, et al. Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes—importance of postprandial glycemia to achieve target HbA1c levels. Diabetes Res Clin Pract. 2007;77:280–5.
CAS
Article
Google Scholar
The DECODE study group, for the European Diabetes Epidemiology Group. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet. 1999;354:617–21.
Hanefeld M, Fischer S, Julius U, et al. Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia. 1996;39:1577–83.
CAS
Article
Google Scholar
Handelsman Y, Bloomgarden ZT, Grunberger G, et al. American Association of Clinical Endocrinologists and American College of Endocrinology: clinical practice guidelines for developing a diabetes mellitus comprehensive care plan—2015. Endocr Pract. 2015;21(Suppl 1):1–87.
Article
Google Scholar
Garber AJ. Treat-to-target trials: uses, interpretation and review of concepts. Diabetes Obes Metab. 2014;16:193–205.
CAS
Article
Google Scholar
Mosenzon O, Raz I. Intensification of insulin therapy for type 2 diabetic patients in primary care: basal-bolus regimen versus premix insulin analogs: when and for whom? Diabetes Care. 2013;36(Suppl 2):S212–8.
CAS
Article
Google Scholar
Garber AJ, Ligthelm R, Christiansen JS, Liebl A. Premixed insulin treatment for type 2 diabetes: analogue or human? Diabetes Obes Metab. 2007;9:630–9.
CAS
Article
Google Scholar
Buse JB, Wolffenbuttel BH, Herman WH, et al. DURAbility of basal versus lispro mix 75/25 insulin efficacy (DURABLE) trial 24-week results: safety and efficacy of insulin lispro mix 75/25 versus insulin glargine added to oral antihyperglycemic drugs in patients with type 2 diabetes. Diabetes Care. 2009;32:1007–13.
CAS
Article
Google Scholar
Su Q, Qian L. Insulin initiation in type 2 diabetes in China. Shang Med J. 2016;39:176–9.
Google Scholar
Tanaka M, Ishii H. Pre-mixed rapid-acting insulin 50/50 analogue twice daily is useful not only for controlling post-prandial blood glucose, but also for stabilizing the diurnal variation of blood glucose levels: switching from pre-mixed insulin 70/30 or 75/25 to pre-mixed insulin 50/50. J Int Med Res. 2010;38:674–80.
CAS
Article
Google Scholar
Rosenstock J, Ahmann AJ, Colon G, Scism-Bacon J, Jiang H, Martin S. Advancing insulin therapy in type 2 diabetes previously treated with glargine plus oral agents: prandial premixed (insulin lispro protamine suspension/lispro) versus basal/bolus (glargine/lispro) therapy. Diabetes Care. 2008;31:20–5.
CAS
Article
Google Scholar
Watada H, Su Q, Li PF, Iwamoto N, Qian L, Yang WY. Comparison of insulin lispro mix 25 with insulin lispro mix 50 as an insulin starter in Asian patients with type 2 diabetes: a phase 4, open-label, randomized trial (CLASSIFY study). Diabetes Metab Res Rev. 2017;33.
Su Q, Liu C, Zheng H, et al. Comparison of insulin lispro mix 25 with insulin lispro mix 50 as insulin starter in Chinese patients with type 2 diabetes mellitus (CLASSIFY study): subgroup analysis of a phase 4, open-label, randomized trial. J Diabetes. 2017;9:575–85.
CAS
Article
Google Scholar
Gupta S, Puppalwar PV, Chalak A. Correlation of fasting and post meal plasma glucose level to increased HbA1c levels in type-2 diabetes mellitus. Int J Adv Med. 2014;1:127–31.
Google Scholar
Saiedullah M, Hayat S, Kamaluddin SM, Begum S. Correlation of fasting and post prandial plasma glucose with hemoglobin glycation. Anwer Khan Mod Med Coll J. 2013;4:28–30.
Article
Google Scholar
Ketema EB, Kibret KT. Correlation of fasting and postprandial plasma glucose with HbA1c in assessing glycemic control; systematic review and meta-analysis. Arch Public Health. 2015;73:43.
Article
Google Scholar
Rosediani M, Azidah AK, Mafauzy M. Correlation between fasting plasma glucose, post prandial glucose and glycated haemoglobin and fructosamine. Med J Malaysia. 2006;61:67–71.
CAS
PubMed
Google Scholar
Swetha NK. Comparison of fasting blood glucose and post prandial blood glucose with HbA1c in assessing the glycemic control. Int J Healthcare Biomed Res. 2014;2:134–9.
Google Scholar
Holman RR, Thorne KI, Farmer AJ, et al. Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes. N Engl J Med. 2007;357:1716–30.
CAS
Article
Google Scholar
Lavernia F. What options are available when considering starting insulin: premix or basal? Diabetes Technol Ther. 2011;13(Suppl 1):S85–92.
Article
Google Scholar
American Diabetes Association. Standards of medical care in diabetes—2016. Diabetes Care. 2016;39(Suppl 1):S1–112.
Google Scholar
Garber AJ, Abrahamson MJ, Barzilay JI, et al. Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm—2016 executive summary. Endocr Pract. 2016;22:84–113.
Article
Google Scholar
Tanenberg R, Zisman A, Stewart J. Glycemia Optimization Treatment (GOT): glycemic control and rate of severe hypoglycemia for five different dosing algorithms of insulin glargine in patients with type 2 diabetes mellitus [abstract]. American Diabetes Association (ADA) 2006; 66th Scientific Sessions:A567-P.
Zafar MI, Ai X, Shafqat RA, Gao F. Effectiveness and safety of Humalog mix 50/50 versus Humalog mix 75/25 in Chinese patients with type 2 diabetes. Ther Clin Risk Manag. 2014;11:27–32.
PubMed
PubMed Central
Google Scholar
Furukawa KD, Yamaaki N, Fujimoto A, Ohyama K, Muramoto H. Simple insulin dose adjustment using 3-3-1 algorithm in Japanese patients with type 2 diabetes: start Kanazawa study (self-titration aggressive algorithm with glargine trial). J Diabetes Mellitus. 2016;6:197–203.
CAS
Article
Google Scholar
Rosenstock J, Schwartz SL, Clark CM Jr, Park GD, Donley DW, Edwards MB. Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin. Diabetes Care. 2001;24:631–6.
CAS
Article
Google Scholar
Yang W, Xu X, Liu X, et al. Treat-to-target comparison between once daily biphasic insulin aspart 30 and insulin glargine in Chinese and Japanese insulin-naive subjects with type 2 diabetes. Curr Med Res Opin. 2013;29:1599–608.
CAS
Article
Google Scholar
Pan CY, Sinnassamy P, Chung KD, Kim KW, LEAD Study Investigators Group. Insulin glargine versus NPH insulin therapy in Asian type 2 diabetes patients. Diabetes Res Clin Pract. 2007;76:111–8.
CAS
Article
Google Scholar
Yabe D, Seino Y, Fukushima M, Seino S. β cell dysfunction versus insulin resistance in the pathogenesis of type 2 diabetes in East Asians. Curr Diab Rep. 2015;15:602.
Shrestha L, Jha B, Yadav B, Sharma S. Correlation between fasting blood glucose, postprandial blood glucose and glycated hemoglobin in non-insulin treated type 2 diabetic subjects. Sunsari Techn Coll J. 2012;1:18–21.
Article
Google Scholar
Yang W, Qian L, Li P. Evaluation of different blood glucose profiles between East Asian and Caucasian insulin-naïve patients with type 2 diabetes mellitus after oral antihyperglycemic medication failure [abstract]. Diabetes Metab Res Rev. 2016;32 (S2):42 A415074.